Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 478

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Interstitial lung disease in polymyositis and dermatomyositis

Marie, I., Hachulla, E., Chérin, P., Dominique, S., Hatron, P.‐Y., Hellot, M.‐F., Devulder, B., Herson, S., Levesque, H., Courtois, H.·2002·Arthritis Care & Research

Abstract

Objectives: To assess prevalence, characteristics, and long‐term outcome of interstitial lung disease (ILD) in polymyositis (PM) and dermatomyositis (DM). To determine predictive variables of ILD course in PM/DM, and to define both clinical and biochemical features associated with ILD onset in PM/DM. Methods: The medical records of 156 consecutive PM/DM patients in 3 medical centers were reviewed. Results: Thirty‐six PM/DM patients (23.1%) developed ILD. We observed that 19.4% of patients with ILD had resolution of pulmonary disorders, whereas 25% experienced ILD deterioration. Morbidity and mortality rates were as high as 13.9% and 36.4%, respectively, in PM/DM patients with ILD. Parameters of PM/DM that related to ILD poor outcome were identified as follows: Hamman‐Rich–like pattern, initial diffusing capacity of carbon monoxide <45%, neutrophil alveolitis, and histologic usual interstitial pneumonia. Additionally, for the group with ILD, polyarthritis, higher values of erythrocyte sedimentation rate and C‐reactive protein, presence of anti–Jo‐1 antibody, and characteristic microangiopathy were significantly more frequent. Conclusion: Our series underlines the high frequency of ILD in PM/DM patients, resulting in increased morbidity and mortality rates. It also indicates that PM/DM patients should routinely be screened for ILD, even those patients without anti–Jo‐1 antibody, because 69% of our ILD patients were seronegative for the anti–Jo‐1 antibody. Our findings further suggest that PM/DM patients presenting with factors predictive of ILD poor outcome may require more aggressive therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.10794

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 478

Metadata

Authors
Marie, I., Hachulla, E., Chérin, P., Dominique, S., Hatron, P. ‐., Hellot, M. ‐., Devulder, B., Herson, S., Levesque, H., & Courtois, H.
Venue
Arthritis Care & Research
Publisher
Wiley
Published
2002-12-12
Volume
47
Issue
6
Pages
614-622
ISSN
  • 0893-7524 (ISSN-L)
  • 1529-0123
OpenAlex
W1974113719
Cited by
478
References
20
FWCI
6.89
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Interstitial lung disease in polymyositis and dermatomyositis. https://app.cochat.ai/papers/10.1002/art.10794
The paper
Marie, I., Hachulla, E., Chérin, P., Dominique, S., Hatron, P. ‐., Hellot, M. ‐., Devulder, B., Herson, S., Levesque, H., & Courtois, H. (2002). Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Care & Research. https://doi.org/10.1002/art.10794

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.